retatrutide efficacy clinical trials and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Weight loss efficacy of selected

In a 2023 study, people taking 2.4 mg of semaglutide each week were nearly twice as likely to see NASH go away, without their liver scarring getting worse, compared to those on a placebo

Regulatory agencies like the FDA require strong safety databases for drugs that will be prescribed to millions of people, and a trial of this size provides the statistical power needed to detect both efficacy signals and uncommon adverse events

Steam or lightly cook greens to reduce volume and make eating larger amounts more practical

At that point, the amount of drug leaving your body is balanced by the amount youre adding with each new dose, creating a reliable therapeutic effect

The 2024 joint scientific statement on nutrition and GLP-1 medications recommends involving a registered dietitian where appropriate, especially for people at risk of inadequate nutrient intake or muscle loss

Cagrilintide shows greater potency and a longer half-life (approximately 7 days) than earlier amylin analogs like Pramlintide, which is why its generating attention in the metabolic optimization space